ActivBiotics Set to Sell Proprietary Assets, Including Drug Product Candidates, on March 14, 2008

    WELLESLEY HILLS, Mass., March 5 /CNW/ -- Joseph F. Finn, Jr., CPA, the
Assignee for the Benefit of Creditors of ActivBiotics, confirmed today that
the sale of ActivBiotics' proprietary assets will be carried out through a
sealed bid at 12:00 PM on March 14, 2008. There has been substantial interest
from various parties about different aspects of the technology. "With 48 bid
packages being reviewed by companies, in addition to comprehensive due
diligence, I believe we'll be able to successfully monetize the assets of the
company," said Joseph F. Finn, Jr. "However, because different parties are
interested in different assets, it is unlikely that sale of all three assets
will go to a single buyer," added Finn.
    For additional information on the terms of sale and to obtain a bidder's
package, please contact Joseph F. Finn, Jr., CPA (,
phone 781-237-8840), Finn, Warnke & Gayton, 167 Worcester Street, Suite 201,
Wellesley Hills, MA  02481-3613. For technical information on the assets,
please contact Christo Shalish,

For further information:

For further information: Christo Shalish of ActivBiotics, Inc., 
+1-617-901-4511, Web Site:

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890